PLUS THERAPEUTICS, INC. — Director's Dealing 2010

Nov 3, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-11-01

Reporting Person: Dean Lloyd H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-11-01	Restricted Stock Award	A	21000	$4.70	Acquired	21000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-11-01	Non-Qualified Stock Option (Right to Buy)	$4.70	A	21000	Acquired	2020-11-01	Common Stock (21000)	Direct

Footnotes

F1: The restricted stock vests fifty percent (50%) on November 1, 2011 and fifty percent (50%) on November 1, 2012, subject to Mr. Dean's continued service to the Company.

F2: The option vests fifty percent (50%) on November 1, 2011, with the remaining options vesting in equal monthly installments over the subsequent year thereafter, subject to Mr. Dean's continued service to the Company